TrialPanorama/TrialPanorama-database huggingface dataset:
Study: NCT06588127

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: nudge
Description: Nudge interventions are developed based on the scoping review and qualitative research by the research team, which involves commitment (behavioral contracts), norms (case and experience sharing), significance and framing effects (posters, health behavior identification posts), reminders, and incentives (arteriosclerosis detection). The content encompasses diet, physical activity, medication management, self-monitoring, and control of smoking and alcohol. From the viewpoint of bounded rationality in behavioral economics, and drawing on prior research that has pinpointed decision-making biases in patients' self-management behaviors, nudging strategies have been developed to assist individuals in overcoming these biases or to utilize the patterns of these biases to steer them toward making choices that are in line with their health.
Study: NCT06604260

Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: 68Ga-FAPi-46
Description: 68Ga FAPi PET-CT scan
Study: NCT06594952

Intervention type: OTHER
Intervention: Questionnaire and Physical Exam
Description: Diagnosis of Anxiety using the state-trait anxiety inventory scale (STAI). Depression using Edinburgh Postnatal Depression Scale (EPDS)~* Coping using the Brief Coping Scale~* Socioeconomic using the Socioeconomic Scale of Egypt~* Personality using the short-form Eysenck Personality Questionnaire-Revised (EPQ-R)~* Behaviour using Impact of Erect Scale (IES-22)

Intervention type: OTHER
Intervention: Questionnaire and Physical Exam
Description: Diagnosis of Anxiety using the state-trait anxiety inventory scale (STAI). Depression using Edinburgh Postnatal Depression Scale (EPDS)~* Coping using the Brief Coping Scale~* Socioeconomic using the Socioeconomic Scale of Egypt~* Personality using the short-form Eysenck Personality Questionnaire-Revised (EPQ-R)~* Behaviour using Impact of Erect Scale (IES-22)

Intervention type: OTHER
Intervention: Questionnaire and Physical Exam
Description: Diagnosis of Anxiety using the state-trait anxiety inventory scale (STAI). Depression using Edinburgh Postnatal Depression Scale (EPDS)~* Coping using the Brief Coping Scale~* Socioeconomic using the Socioeconomic Scale of Egypt~* Personality using the short-form Eysenck Personality Questionnaire-Revised (EPQ-R)~* Behaviour using Impact of Erect Scale (IES-22)
Study: NCT06594315

Intervention type: DRUG
Intervention: Deuterated Glucose
Description: Given orally

Intervention type: DRUG
Intervention: Deuterated Glucose
Description: Given orally

Intervention type: DRUG
Intervention: Deuterated Glucose
Description: Given orally

Intervention type: PROCEDURE
Intervention: Magnetic Resonance Imaging (MRI)
Description: Imaging procedure performed at University of California, San Francisco

Intervention type: PROCEDURE
Intervention: Magnetic Resonance Imaging (MRI)
Description: Imaging procedure performed at University of California, San Francisco

Intervention type: PROCEDURE
Intervention: Magnetic Resonance Imaging (MRI)
Description: Imaging procedure performed at University of California, San Francisco

Intervention type: PROCEDURE
Intervention: Blood Sample
Description: Capillary blood from the fingertip

Intervention type: PROCEDURE
Intervention: Blood Sample
Description: Capillary blood from the fingertip

Intervention type: PROCEDURE
Intervention: Blood Sample
Description: Capillary blood from the fingertip

Intervention type: PROCEDURE
Intervention: MR spectroscopy (MRS)
Description: Imaging procedure performed at University of California, San Francisco

Intervention type: PROCEDURE
Intervention: MR spectroscopy (MRS)
Description: Imaging procedure performed at University of California, San Francisco

Intervention type: PROCEDURE
Intervention: MR spectroscopy (MRS)
Description: Imaging procedure performed at University of California, San Francisco
Study: NCT06587867

Intervention type: BIOLOGICAL
Group type: OTHER
Intervention: efgartigimod
Description: active drug efgartigimod to be administer
Study: NCT06596902

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Physical Activity
Description: The 12-month intervention will progressively increase in intensity and complexity to teach parents/children more complex sports skills and behavioral techniques, to prepare them to become future team leaders for nutrition education and sports sessions. In addition, the family Olympics events will take place after every 3-month to reinforce progression, social support; progressive improvements: Phase 1: Beginner (months 0-3) will focus on introductory concepts and basic sports skills and will focus on establishing consistent behavioral patterns and social support. Phase 2: Intermediate (months 4-6) will begin to introduce slightly more complex nutrition behavioral concepts and increase difficulty of sport skills, and reinforce behavioral patterns from phase 1. Phase 4: Advanced (months 10-12) will teach parents and children advanced sports skills ; nutrition knowledge so that they may become team leaders to help implement future activity sessions and nutrition education sessions.
Study: NCT06586684

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Inclisiran
Description: Patients with carotid plaques undergoing treatment with inclisiran
Study: NCT06599190

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: pelvic floor exercises, nutritional instructions
Description: They will receive nutritional instructions and pelvic floor muscle exercises three sessions/week for 3 months.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: abdominal hypopressive exercises, pelvic floor exercises, nutritional instructions
Description: consists of 25 female athletes. They will receive the same treatment for the control group and abdominal hypopressive exercises three sessions/week of 30 mins per week for 3 months.
Study: NCT06595901

Intervention type: OTHER
Intervention: Actigraph
Description: Participants will wear an Actigraph hip-worn accelerometer on their non-dominant hip during all waking hours, and on the wrist while sleeping

Intervention type: OTHER
Intervention: Questionnaires
Description: * Patient Health Questionnaire Anxiety and Depression Scale30 (PHQ-ADS), a validated composite of anxiety and depressive symptoms.~* Self-reported cognition will be assessed by the Functional Assessment of Cancer Therapy-Cognitive (FACT-Cog).

Intervention type: OTHER
Intervention: BrainBaseline application
Description: Objective measures of cognitive function will include those from the BrainBaseline application, a validated research tool developed by Digital Artefacts to remotely measure domains of cognition

Intervention type: OTHER
Intervention: Semi-structured interviews
Description: Semi-structured individual interviews will be conducted with up to 15 healthcare stakeholders and 15-30 patients with breast cancer at any time during the study period, as determined by participant preference.

Intervention type: OTHER
Intervention: Semi-structured interviews
Description: Semi-structured individual interviews will be conducted with up to 15 healthcare stakeholders and 15-30 patients with breast cancer at any time during the study period, as determined by participant preference.
Study: NCT06600516

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: CBTi: Stimulus Control Core
Description: Stimulus control.45 People with insomnia may fail to associate the bedroom with sleep, and instead may associate it with worrying, planning, or recreation. Stimulus control includes the following instructions: (1) go to bed only when sleepy; (2) only use your bed or bedroom for sleep (or sex); (3) if you do not fall asleep quickly (i.e., 15 minutes), leave the bed, do something in another room, and return to bed only when you feel a strong sleep urge; (4) if you do not fall asleep quickly upon returning to bed, repeat instruction 3; (5) use your alarm to awaken at the same time every morning regardless of duration of sleep obtained; and (6) do not take long naps.

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: CBTi: Sleep Restriction Core
Description: Sleep restriction.46 People with insomnia often spend too much time awake in bed. Sleep restriction modifies the participant's sleep window so total time in bed is no more than 30 minutes beyond their average total sleep time to consolidate sleep, thus improving depth, continuity, and consistency. As the participant's sleep efficiency improves with treatment (i.e., the percentage of total time spent asleep within the sleep window), their sleep window is also increased. However, the shortened sleep window often causes increased anxiety.

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: CBTi: Sleep Compression Core
Description: Sleep compression.47,48 Sleep compression encourages time-in-bed restrictions. Unlike sleep restriction, sleep compression allows a gradual reduction in time-in-bed over the course of multiple weeks. Typically, average total sleep time and total time in bed values are calculated from one or more weeks of daily sleep diaries. The difference between these two values is then divided by the number of weeks remaining and the allotted time in bed duration is compressed by this calculated value weekly, by delaying bedtime or advancing wake time.
Study: NCT06587542

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Injection of protein purified derivative
Description: Injection of purified protein derivative for anogenital warts in HIV and non HIV patient, on the largest lesion

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Injection of protein purified derivative
Description: Injection of purified protein derivative for anogenital warts in HIV and non HIV patient, on the largest lesion
Study: NCT06600555

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: metabolic surgery with SLEEVE technique
Description: metabolic surgery with SLEEVE technique

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: metabolic surgery with BY-PASS technique
Description: metabolic surgery with BY-PASS technique
Study: NCT06586905

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Medical Device
Description: Multiplo Complete Syphilis (TP/nTP) Antibody Test
Study: NCT06593535

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Placebo (Placebo trial)
Description: The Placebo capsule supplement was taken for 4 days (7 capsules per day)

Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Placebo (Placebo trial)
Description: The Placebo capsule supplement was taken for 4 days (7 capsules per day)

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Astaxanthin (AST trial)
Description: The AST capsule supplement was taken for 4 days, with a daily dosage of 28 mg of AST (equivalent to 7 capsules per day, each containing 4 mg of AST).

Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Astaxanthin (AST trial)
Description: The AST capsule supplement was taken for 4 days, with a daily dosage of 28 mg of AST (equivalent to 7 capsules per day, each containing 4 mg of AST).
Study: NCT06602700

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: HIIT
Description: high-intensity interval training

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: MICT
Description: moderate-intensity continuous training
Study: NCT06587698

Intervention type: DRUG
Group type: OTHER
Intervention: Sitagliptin
Description: 100 mg QD for 3 month

Intervention type: DRUG
Group type: OTHER
Intervention: BeiDouGen
Description: 60 mg BID for 3 month

Intervention type: DRUG
Group type: OTHER
Intervention: Sitagliptin+BeiDouGen
Description: 100 mg Sitagliptin QD plus BeiDouGen 60 mg BID for 3 month
Study: NCT06547619

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Insulin aspart
Description: insulin aspart is perfused at 5 ascending concentrations (10\^-8M - 10\^-4 M) for 10 minutes each

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Insulin aspart
Description: insulin aspart is perfused at 5 ascending concentrations (10\^-8M - 10\^-4 M) for 10 minutes each

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Insulin aspart
Description: insulin aspart is perfused at 5 ascending concentrations (10\^-8M - 10\^-4 M) for 10 minutes each

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Insulin aspart
Description: insulin aspart is perfused at 5 ascending concentrations (10\^-8M - 10\^-4 M) for 10 minutes each
Study: NCT06595225

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Nutrition education sessions
Description: Participants received nutrition education each month, covering topics ranging from general nutrition knowledge, nutrition knowledge related to their diagnosis of living with HIV infection whether during the acute or chronic phase. In addition, specific information was shared about other comorbidities the participant could be living with, finally information was shared on ways to improve mental health and enhance physical activity levels.
Study: NCT05878418

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Thoracolumbosacral Spinal Orthosis (TLSO)
Description: In the TE, PR, PC + spinal orthosis group, in addition to the control group program, a thoracolumbosacral spinal orthosis (TLSO) designed specifically for the child will be used for 8 hours a day for 8 weeks, every day of the week.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Trunk Exercise (TE), Pulmonary Rehabilitation(PR) and Pulmonary Care (PC)
Description: The active control group will receive a TE, PR and PC program in the outpatient clinic once a week for 8 weeks, 7 days a week, once a day, 50-60 minutes per session, for 8 weeks.

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Trunk Exercise (TE), Pulmonary Rehabilitation(PR) and Pulmonary Care (PC)
Description: The active control group will receive a TE, PR and PC program in the outpatient clinic once a week for 8 weeks, 7 days a week, once a day, 50-60 minutes per session, for 8 weeks.
Study: NCT06586697

Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: Thoracic Radiotherapy
Description: Thoracic Radiotherapy (45Gy /1.5Gy/bid/3w)
Study: NCT06705582

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Fortified Bread
Description: Intervention group will be supplied with fortified bread delivering 10 -15 μg (400-600 IU) vitamin D3 in a daily portion and will receive dietary advice to incorporate fortified foods that are commonly available on the market in their diet.

Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Unfortified bread
Description: Placebo control group will be supplied with unfortified bread and will receive dietary advice to incorporate fortified foods that are commonly available on the market in their diet.
Study: NCT06705647

Intervention type: OTHER
Intervention: Chronic Obstructive Pulmonary Disease (COPD)
Description: The base line acoustic and mel frequency ceprtum coefficients will be analysed statistically between COPD voices and healthy control groups to highlight the correlation between COPD and its effects on voice production.

Intervention type: OTHER
Intervention: Chronic Obstructive Pulmonary Disease (COPD)
Description: The base line acoustic and mel frequency ceprtum coefficients will be analysed statistically between COPD voices and healthy control groups to highlight the correlation between COPD and its effects on voice production.
Study: NCT06704412

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: floss band
Description: The floss band intervention used the standard floss band technique, wrapping a floss band (lime green Sanctband Comprefloss™, 2 × 3.5 m; PENTEL, Shah Alam, Malaysia) made of natural rubber tightly around the ankle on the affected side. It was started at the fifth metatarsal and wrapped horizontally around the metatarsals twice, in a figure eight to the medial malleolus, over the Achilles tendon and the lateral malleolus three times, and around the medial malleolus again, before being passed twice from the medial mal-leolus over the Achilles tendon to the lateral malleolus, forming an end knot

Intervention type: BEHAVIORAL
Group type: SHAM_COMPARATOR
Intervention: Sham (No Treatment)
Description: The wrap used in the sham group lacked the elasticity of a floss band; the ankle was wrapped in the same manner, but loosely to facilitate blood circulation. Similarly, the participants were instructed to perform low-intensity active exercise involving ankle DF and plantar flexion for 2 minutes after applying the sham floss band. Finally, the sham floss band was removed, and the patient was asked to walk lightly on level ground for about 1 minute under the same conditions as in the floss band group.
Study: NCT06705790

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Pelvic Floor Muscle Training
Description: Pelvic floor muscle training 5x/week for 12-weeks
Study: NCT06704828

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: SHR-4602
Description: SHR-4602
Study: NCT06704568

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: exercise
Description: Unlike the control group; core exercises for 20-30 minutes, 3 days a week for 8 weeks, and respiratory exercises combined with core exercises for the respiratory exercises group: Slow and controlled breathing exercises will be performed starting with 5 seconds of inhalation and 5 seconds of exhalation twice a day for 10 minutes, 5 days a week for eight weeks, with a 10-second diaphragmatic breathing cycle (6 breaths/minute). The finger counting method will be recommended so that participants can easily follow the 5-second inhalation and 5-second exhalation cycles. The exercises can be done sitting or lying down. The individuals will be taught the differences between the two by switching between normal and deep breathing a few times. The respiratory exercises will be finished with relaxation exercises.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: exercise
Description: Unlike the control group; core exercises for 20-30 minutes, 3 days a week for 8 weeks, and respiratory exercises combined with core exercises for the respiratory exercises group: Slow and controlled breathing exercises will be performed starting with 5 seconds of inhalation and 5 seconds of exhalation twice a day for 10 minutes, 5 days a week for eight weeks, with a 10-second diaphragmatic breathing cycle (6 breaths/minute). The finger counting method will be recommended so that participants can easily follow the 5-second inhalation and 5-second exhalation cycles. The exercises can be done sitting or lying down. The individuals will be taught the differences between the two by switching between normal and deep breathing a few times. The respiratory exercises will be finished with relaxation exercises.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: exercise
Description: Unlike the control group; core exercises for 20-30 minutes, 3 days a week for 8 weeks, and respiratory exercises combined with core exercises for the respiratory exercises group: Slow and controlled breathing exercises will be performed starting with 5 seconds of inhalation and 5 seconds of exhalation twice a day for 10 minutes, 5 days a week for eight weeks, with a 10-second diaphragmatic breathing cycle (6 breaths/minute). The finger counting method will be recommended so that participants can easily follow the 5-second inhalation and 5-second exhalation cycles. The exercises can be done sitting or lying down. The individuals will be taught the differences between the two by switching between normal and deep breathing a few times. The respiratory exercises will be finished with relaxation exercises.
Study: NCT06704399

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Acceptance and Commitment Therapy-Based Psychoeducation
Description: Psychoeducation based on acceptance and commitment therapy will be applied to the experimental group.

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: control group
Description: No intervention will be applied to the control group.
Study: NCT06704958

Intervention type: OTHER
Group type: OTHER
Intervention: AMPERE EMA app
Description: AMPERE EMA smartphone app using MyCap
Study: NCT06705075

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Perfluten
Description: Use of UCA Definity to evaluate uterine fibroids by contrast-enhanced ultrasound (CEUS) and subharmonic-aided pressure estimation (SHAPE) pre and post-uterine artery embolization (UAE).
Study: NCT06705868

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Diet-Time-restricted eating (TRE)
Description: Ad libitum time-restricted scheme with a further time-restriction on fruit and vegetable consumption in participants with MASLD

Intervention type: OTHER
Group type: OTHER
Intervention: Lifestyle Management
Description: The SoC intervention refers to an adaptation of a healthier lifestyle in elements that have to do with weight management, adopting healthier dietary habits, alcohol intake reduction, increase physical activity levels.
Study: NCT06351124

Intervention type: BIOLOGICAL
Group type: ACTIVE_COMPARATOR
Intervention: Feasibility of beta-hydroxybutyrate supplementation to reduce inflammation in patients with Crohn's
Description: Is Beta-hydroxybutyrate a supplement that can control symptoms and progression of Crohn's.
Study: NCT06279351

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Thalidomide+cetuximab+FOLFOX/FOLFIRI
Description: Thalidomide+cetuximab+FOLFOX/FOLFIRI
Study: NCT06473389

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Suprascapular nerve pulse radiofrequency ablation
Description: Pulse RF application will be applied to the suprascapular nerve once under US guidance with a TOP-TLG10 STP generator at a maximum temperature of 42 degrees, 2 Hz, 20 ms and 45 V for 2 minutes.

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Suprascapular Nerve Block Group
Description: Suprascapular block will be applied once with a mixture consisting of 5 ml (1 ml betamethasone, 2% lidocaine 2 ml, 0.9% saline 2 ml).

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Steroid Group
Description: Intra-articular steroid application will be made with a mixture consisting of 5 ml (2 ml of 2% lidocaine, 2 ml of 0.9% saline and 1 ml of betamethasone 5 mg).
Study: NCT04478201

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: back sleep positioning
Description: sleeping on the back.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: side sleep positioning
Description: sleeping on the side
Study: NCT05390372

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: human milk
Description: For skin damage care of preterm newborns randomly assigned to the breast milk group, their own breast milk will be applied topically once every 60 minutes until complete healing. Skin damage in newborns will be evaluated by an independent nurse and specialist doctor for 60 minutes during the treatment, and the score will be given and recorded. A minimum decrease of 1 point in the skin condition assessment scale score will be considered to indicate 'improvement'. The decision that the skin integrity of the newborn is completely healed will be made by the neonatal doctor independent of the trial. Areas between 0-3 on the newborn skin condition assessment scale will be considered healed. Breastfeeding does not have any side effects in preterm newborns.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Routine care group
Description: cream applied as part of hospital routine practice